Association between Fluid Balance and Treatment Outcome of Ibuprofen for Patent Ductus Arteriosus in Preterm Infants

被引:1
|
作者
Liu, Chang [1 ,2 ,3 ,4 ]
Shi, Yuan [1 ,2 ,3 ,4 ]
机构
[1] Chongqing Med Univ, Childrens Hosp, Dept Neonatol, Chongqing 400014, Peoples R China
[2] Natl Clin Res Ctr Child Hlth & Disorders, Chongqing 400014, Peoples R China
[3] Minist Educ, Key Lab Child Dev & Disorders, Chongqing 400014, Peoples R China
[4] Chongqing Key Lab Pediat, Chongqing 400014, Peoples R China
关键词
patent ductus arteriosus; fluid balance; ibuprofen; preterm infants; BRONCHOPULMONARY DYSPLASIA; GROWTH VELOCITY; RISK-FACTORS; RESTRICTION; CLOSURE; LIFE; PREDICTORS; MANAGEMENT;
D O I
10.31083/j.rcm2403078
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Excessive fluid intake is a predictor of the development of patent ductus arteriosus (PDA) in preterm infants. Previous studies have examined the relationship between fluid intake and outcomes following ibuprofen for PDA. However, there is a lack of data to determine whether fluid balance has an effect on ibuprofen treatment for PDA. Therefore, this study sought to determine the relationship between fluid balance and outcomes following treatment with ibuprofen for PDA. Methods: We conducted a retrospective study of 110 infants admitted to the Children's Hospital of Chongqing Medical University between January 2017 and April 2022, who were treated with ibuprofen for hemodynamically significant PDA (hsPDA). We calculated the average fluid balance before and during the two courses of ibuprofen treatment and whether they were significantly associated with outcomes in hsPDA patients. Results: In the first course of ibuprofen treatment (FIT), responders had lower fluid balance before FIT compared to non-responders [median 31.82 (18.01, 39.66) vs 34.68 (25.31, 43.56) mL/kg/day; p = 0.049], while the fluid balance during FIT [median 40.61 (33.18, 63.06) vs 42.65 (30.02, 57.96) mL/kg/day; p = 0.703] did not differ between responders and non-responders. Fluid balance before the second course of ibuprofen treatment (SIT) (mean 41.58 +/- 14.26 vs 35.74 +/- 10.99 mL/kg/day; p = 0.322) and during SIT (mean 39.21 +/- 12.65 vs 37.00 +/- 21.38 mL/kg/day; p = 0.813) was not found to have a significant association with SIT outcome. Multivariate logistic regression analysis showed fluid balance before FIT was a predictor for FIT success [Odds ratio (OR): 0.967; 95% confidence interval (CI): 0.935-0.999; p = 0.042]. Fluid balance within the first week of life had a greater association with the FIT outcome (OR: 0.967, 95% CI: 0.939-0.996, p = 0.027). Gestational diabetes mellitus and higher Apgar scores decreased the possibility of PDA closure after FIT. Conclusions: Lower fluid balance before FIT, especially within the first week of life appeared to be a predictor for closure of hsPDA after FIT in preterm infants.
引用
收藏
页数:10
相关论文
共 50 条
  • [31] Current controversies in the management of patent ductus arteriosus in preterm infants
    Ibrahim, Thowfique K.
    Haium, A. A. Abdul
    Chandran, S.
    Rajadurai, V. S.
    INDIAN PEDIATRICS, 2014, 51 (04) : 289 - 294
  • [32] Treatment of patent ductus arteriosus with ibuprofen
    VanOvermeire, B
    Follens, I
    Hartmann, S
    Creten, WL
    VanAcker, KJ
    ARCHIVES OF DISEASE IN CHILDHOOD-FETAL AND NEONATAL EDITION, 1997, 76 (03): : F179 - F184
  • [33] Oral paracetamol versus oral ibuprofen for treatment of patent ductus arteriosus
    Al-lawama, Manar
    Alammori, Iyad
    Abdelghani, Tariq
    Badran, Eman
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2018, 46 (02) : 811 - 818
  • [34] Factors affecting the effectiveness of oral ibuprofen in the treatment of patent ductus arteriosus in preterm infants
    Chaohui Ye
    Qin Lyu
    Linyan Jiang
    Li Yu
    Yinquan Xu
    Jie Zhang
    Xiaodong Lu
    International Journal of Clinical Pharmacy, 2021, 43 : 1074 - 1081
  • [35] Ibuprofen for the treatment of patent ductus arteriosus in preterm or low birth weight (or both) infants
    Ohlsson, Arne
    Walia, Rajneesh
    Shah, Sachin S.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2020, (02):
  • [36] Repeated Courses of Oral Ibuprofen in Premature Infants with Patent Ductus Arteriosus: Efficacy and Safety
    Olgun, Hasim
    Ceviz, Naci
    Kartal, Ibrahim
    Caner, Ibrahim
    Karacan, Mehmet
    Tastekin, Ayhan
    Becit, Necip
    PEDIATRICS AND NEONATOLOGY, 2017, 58 (01) : 29 - 35
  • [37] The influence on renal function of ibuprofen treatment for patent ductus arteriosus in extremely low birthweight infants
    Nishizaki, Naoto
    Matsuda, Akina
    Yoneyama, Toshiyuki
    Watanabe, Akiko
    Obinata, Kaoru
    Shimizu, Toshiaki
    PEDIATRICS INTERNATIONAL, 2020, 62 (02) : 193 - 199
  • [38] Continuous Infusion of Ibuprofen for Treatment of Patent Ductus Arteriosus in Very Low Birth Weight Infants
    Lago, Paola
    Salvadori, Sabrina
    Opocher, Francesca
    Ricato, Silvia
    Chiandetti, Lino
    Frigo, Anna Chiara
    NEONATOLOGY, 2014, 105 (01) : 46 - 54
  • [39] Evaluation of the association between patent ductus arteriosus approach and neurodevelopment in extremely preterm infants
    Cervera, Soledad Belen
    Saeed, Sahar
    Luu, Thuy Mai
    Gorgos, Andrea
    Beltempo, Marc
    Claveau, Martine
    Basso, Olga
    Lapointe, Anie
    Tremblay, Sophie
    Altit, Gabriel
    JOURNAL OF PERINATOLOGY, 2024, 44 (03) : 388 - 395
  • [40] Renal effects of ibuprofen for the treatment of patent ductus arteriosus in premature infants
    Giniger, R. P.
    Buffat, C.
    Millet, V.
    Simeoni, U.
    JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE, 2007, 20 (04) : 275 - 283